What is the approximate price per bottle of Mitotane? Is it reimbursable?

Mitotane, also known as Mitotane, is an oral anti-tumor drug used to treat adrenocortical cancer (ACC). The drug is currently on the market in China as an original drug. However, due to its short time on the market, it has not yet been included in the national medical insurance catalog. Therefore, when purchased in domestic hospitals or pharmacies, in most cases, it cannot enjoy medical insurance reimbursement. Patients still need to bear all costs during the actual drug purchase process.

Regarding prices, since domestic drug prices have not yet been fully disclosed and unified, it is recommended that patients consult regular hospital pharmacies or drug service platforms before purchasing. Currently in foreign markets, the original version of mitotane generally comes in European and Turkish versions. The common specifications are 500mg100 tablets per box, and the price is about 9,000 yuan. This price will vary due to exchange rate fluctuations and different supply channels. In some areas, the price may be slightly higher or lower than this range.

In addition to original drugs, patients can also choose overseas generic versions. For example, the generic version of mitotane produced by a Lao pharmaceutical factory is consistent with the original drug in terms of ingredients and dosage, but the price is more affordable. It is also 500mg*100 tablets per box, usually priced at more than 2,000 yuan. For some patients with greater financial pressure, generic drugs can be an alternative, but the prerequisite is to ensure regular channels and reliable drug quality.

Generally speaking, although mitotane has been launched in China, it is not covered by medical insurance, and the price is high and the financial burden is high. Regardless of whether they choose domestic original drugs or overseas generic drugs, patients should consult a professional doctor before taking the drug to clarify the course of treatment and medication method, and conduct regular follow-up monitoring to ensure the treatment effect and medication safety. At the same time, you can also pay attention to the adjustment information of the national drug and medical insurance catalog to learn whether it is possible to be included in medical insurance in the future.

Reference materials:https://go.drugbank.com/drugs/DB00648